HIFIBIO
HiFiBiO is a biotherapeutics company that mobilizes the human immune system to combat disease. It commercializes proprietary single-cell technologies for applications in drug and biomarker discovery and development. It also aspires to benefit patients through open-innovation partnerships with industry and academia. HiFiBiO integrates deep-rooted biological expertise with its comprehensive single-cell profiling technologies to discover and accelerate a pipeline of antibody drugs to treat cancer and autoimmune disorders. The company was founded in 2013 and is headquartered in Paris, Ille-de-France.
HIFIBIO
Industry:
Biopharma Biotechnology Pharmaceutical Therapeutics
Founded:
2013-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.hifibio.com
Total Employee:
101+
Status:
Active
Contact:
+33179350790
Total Funding:
179.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Apache Wordpress Plugins
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-10-15 | H-Immune Therapeutics | H-Immune Therapeutics acquired by HiFiBiO | N/A |
Investors List
Grand Mount Capital
Grand Mount Capital investment in Series D - HiFiBiO
IDG Capital
IDG Capital investment in Series D - HiFiBiO
Mirae Asset Capital
Mirae Asset Capital investment in Series D - HiFiBiO
Legend Star
Legend Star investment in Series D - HiFiBiO
Maison Capital
Maison Capital investment in Series D - HiFiBiO
Sequoia Capital China
Sequoia Capital China investment in Series D - HiFiBiO
Hengxu Capital
Hengxu Capital investment in Series D - HiFiBiO
Sherpa Venture Capital
Sherpa Venture Capital investment in Series D - HiFiBiO
B Capital Group
B Capital Group investment in Series D - HiFiBiO
Hong Kong Science and Technology Parks Corporation (HKSTP)
Hong Kong Science and Technology Parks Corporation (HKSTP) investment in Series D - HiFiBiO
Official Site Inspections
http://www.hifibio.com Semrush global rank: 5.53 M Semrush visits lastest month: 1.54 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
